SCHEMBL3389946

SCHEMBL3389946

C=C(C=O)OCc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.52
TDP1 Q9NUW8 2/20 0.50
MAPK1 P28482 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
SLC6A2 P23975 1/20 0.50
SLC6A3 Q01959 1/20 0.50
KMT2A Q03164 1/20 0.50
HCAR2 Q8TDS4 1/20 0.50
LMNA P02545 3/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
CA12 O43570 2/20 0.46
CA9 Q16790 2/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
AKR1B10 O60218 1/20 0.44
AKR1B1 P15121 1/20 0.44
CA4 P22748 1/20 0.44
CA6 P23280 1/20 0.44
CA5A P35218 1/20 0.44
CA7 P43166 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18296891 0.82 ALDH1A1 (0.48) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2
SCHEMBL29068640 0.82 ALDH1A1 (0.48) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2
SCHEMBL15109190 0.79 ALDH1A1 (0.52) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2
SCHEMBL2678884 0.78 ALDH1A1 (0.59) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2
SCHEMBL26288 0.78 HCAR2 (0.67) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2
SCHEMBL23788401 0.77 ALDH1A1 (0.53) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2
SCHEMBL20442538 0.77 LMNA (0.49) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2
SCHEMBL19057196 0.76 ALDH1A1 (0.56) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2
SCHEMBL27509184 0.76 ALDH1A1 (0.56) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2
SCHEMBL4246837 0.76 ALDH1A1 (0.56) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119639251-A Self-dispersion pigment and preparation method thereof, aqueous dispersion containing self-dispersion pigment and application of aqueous dispersion 珠海传美讯新材料股份有限公司 2025-03-18 CN claimed
CN-119639251-A Self-dispersion pigment and preparation method thereof, aqueous dispersion containing self-dispersion pigment and application of aqueous dispersion 珠海传美讯新材料股份有限公司 2025-03-18 CN disclosed
US-11632955-B2 Heterocyclic compound and harmful arthropods control agent comprising the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-04-25 US disclosed
CN-110035994-B Heterocyclic compound and harmful arthropod control composition containing same 住友化学株式会社 2022-10-18 CN disclosed
EP-3549933-B1 HETEROCYCLIC COMPOUND, AND ARTHROPOD PEST CONTROL COMPOSITION CONTAINING SAME SUMITOMO CHEMICAL CO (JP) 2022-02-16 EP disclosed
EP-3613730-A1 METHOD FOR PRODUCING PYRIDINE COMPOUND Sumitomo Chemical Company, Limited (JP) 2020-02-26 EP disclosed
EP-3549933-A1 HETEROCYCLIC COMPOUND, AND ARTHROPOD PEST CONTROL COMPOSITION CONTAINING SAME Sumitomo Chemical Company, Limited (JP) 2019-10-09 EP disclosed
WO-2010042600-A2 PHOTO-ACTIVATABLE THERAPEUTIC AGENTS AND METHODS OF USING THE UAB RESEARCH FOUNDATION (US) 2010-04-15 WO disclosed
CN-1134426-C Method for preparing substituted benzodihydropyran derivative ���ƻ�ѧ������˾ 2004-01-14 CN disclosed
EP-1013652-B1 Process for preparation of substituted chromanderivatives BASF AG (DE) 2002-08-14 EP disclosed
US-6136986-A REACTING SUBSTITUTED ACROLEIN COMPOUND WITH ACRYLATES, ACROLEINS, ACROLEIN ACETALS, ALLYL ALCOHOLS OR ALLYL ETHERS TO GIVE 3,4-DIHYDRO-2H-PYRANS, REACTING WITH ACID, FOLLOWED BY REACTING WITH SUBSTITUETED VINYL KETONE, DEHYDROGENATION BASF AKTIENGESELLSCHAFT (DE) 2000-10-24 US disclosed
CN-1264705-A Method for preparing substituted benzodihydropyran derivative BASF AG (DE) 2000-08-30 CN disclosed
EP-1013652-A2 Process for preparation of substituted chromanderivatives BASF AKTIENGESELLSCHAFT (DE) 2000-06-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11632955-B2 Heterocyclic compound and harmful arthropods control agent comprising the same DDT, ACHE, NISCH ALDH1A1 1347/4885TDP1 3244/4885MAPK1 2343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.